Literature DB >> 23489184

The incidence of metabolic syndrome in obese Czech children: the importance of early detection of insulin resistance using homeostatic indexes HOMA-IR and QUICKI.

D Pastucha1, R Filipčíková, D Horáková, L Radová, Z Marinov, J Malinčíková, M Kocvrlich, S Horák, M Bezdičková, M Dobiáš.   

Abstract

Common alimentary obesity frequently occurs on a polygenic basis as a typical lifestyle disorder in the developed countries. It is associated with characteristic complex metabolic changes, which are the cornerstones for future metabolic syndrome development. The aims of our study were 1) to determine the incidence of metabolic syndrome (based on the diagnostic criteria defined by the International Diabetes Federation for children and adolescents) in Czech obese children, 2) to evaluate the incidence of insulin resistance according to HOMA-IR and QUICKI homeostatic indexes in obese children with and without metabolic syndrome, and 3) to consider the diagnostic value of these indexes for the early detection of metabolic syndrome in obese children. We therefore performed anthropometric and laboratory examinations to determine the incidence of metabolic syndrome and insulin resistance in the group of 274 children with obesity (128 boys and 146 girls) aged 9-17 years. Metabolic syndrome was found in 102 subjects (37 %). On the other hand, the presence of insulin resistance according to QUICKI <0.357 was identified in 86 % and according to HOMA-IR >3.16 in 53 % of obese subjects. This HOMA-IR limit was exceeded by 70 % children in the MS(+) group, but only by 43 % children in the MS(-) group (p<0.0001). However, a relatively high incidence of insulin resistance in obese children without metabolic syndrome raises a question whether the existing diagnostic criteria do not falsely exclude some cases of metabolic syndrome. On the basis of our results we suggest to pay a preventive attention also to obese children with insulin resistance even if they do not fulfill the actual diagnostic criteria for metabolic syndrome.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23489184     DOI: 10.33549/physiolres.932438

Source DB:  PubMed          Journal:  Physiol Res        ISSN: 0862-8408            Impact factor:   1.881


  5 in total

1.  Prevalence of Metabolic Syndrome and Impaired Glucose Metabolism among 10- to 17-Year-Old Overweight and Obese Lithuanian Children and Adolescents.

Authors:  Natalija Smetanina; Raimondas Valickas; Astra Vitkauskiene; Kerstin Albertsson-Wikland; Rasa Verkauskienė
Journal:  Obes Facts       Date:  2021-05-05       Impact factor: 3.942

2.  Policaptil Gel Retard significantly reduces body mass index and hyperinsulinism and may decrease the risk of type 2 diabetes mellitus (T2DM) in obese children and adolescents with family history of obesity and T2DM.

Authors:  Stefano Stagi; Elisabetta Lapi; Salvatore Seminara; Paola Pelosi; Paolo Del Greco; Laura Capirchio; Massimo Strano; Sabrina Giglio; Francesco Chiarelli; Maurizio de Martino
Journal:  Ital J Pediatr       Date:  2015-02-15       Impact factor: 2.638

3.  Whole-body and hepatic insulin resistance in obese children.

Authors:  Lorena del Rocío Ibarra-Reynoso; Liudmila Pisarchyk; Elva Leticia Pérez-Luque; Ma Eugenia Garay-Sevilla; Juan Manuel Malacara
Journal:  PLoS One       Date:  2014-11-20       Impact factor: 3.240

4.  Comparison of various steady state surrogate insulin resistance indices in diagnosing metabolic syndrome.

Authors:  Sikandar Hayat Khan; Ali Nawaz Khan; Nayyer Chaudhry; Roomana Anwar; Nadeem Fazal; Muhammad Tariq
Journal:  Diabetol Metab Syndr       Date:  2019-06-14       Impact factor: 3.320

5.  Different Criteria for the Definition of Insulin Resistance and Its Relation with Dyslipidemia in Overweight and Obese Children and Adolescents.

Authors:  Carlos Alberto Nogueira-de-Almeida; Elza Daniel de Mello
Journal:  Pediatr Gastroenterol Hepatol Nutr       Date:  2018-01-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.